CU Anschutz-Led Team Publishes National Roadmap for First Approved Immunotherapy for Newly Diagnosed Type 1 Diabetes in Children
November 11, 2026
November 11, 2026
NEW YORK, Nov. 11 -- Breakthrough T1D (formerly JDRF) a non-profit dedicated to funding type 1 diabetes research, posted the following news release:
* * *
CU Anschutz-Led Team Publishes National Roadmap for First Approved Immunotherapy for Newly Diagnosed Type 1 Diabetes in Children
*
Diabetes Care perspective, developed by experts across the country and endorsed by Breakthrough T1D and the Pediatric Endocrine Society, helps pediatric diabetes . . .
* * *
CU Anschutz-Led Team Publishes National Roadmap for First Approved Immunotherapy for Newly Diagnosed Type 1 Diabetes in Children
*
Diabetes Care perspective, developed by experts across the country and endorsed by Breakthrough T1D and the Pediatric Endocrine Society, helps pediatric diabetes . . .